首页> 外文期刊>World Journal of Gastroenterology >Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX_2 tumor in rabbits by intravenous injection
【24h】

Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX_2 tumor in rabbits by intravenous injection

机译:羟磷灰石纳米颗粒对静脉注射兔肝VX_2肿瘤生长及p53 / c-Myc蛋白表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To evaluate the effect of hydroxyapatite nanoparticles (Nano HAP) by intravenous injection on the inhibition of implanted hepatic VX_2 tumor growth in rabbits and cell p53/c-Myc protein expression. METHODS: 60 hepatic VX_2 tumor-bearing rabbits was randomly divided into five groups. Nano HAP collosol 20 mg/kg, 40 mg/kg, 5-FU solutions 20 mg/mL, mixed liquor of 5-FU solution 20 mg/mL and Nano HAP collosol 20 mg/kg were infused by vein, normal saline conducted as the control. The general state, weight, liver function and gross tumor volume were detected dynamically. The expression of p53 and c-Myc gene protein in tumor tissue was detected by immunohistochemistry methods. RESULTS: The growth of implanted hepatic VX_2 tumors was significantly inhibited in all therapy groups, 3 wk after the injection, the tumor control rates in Nano HAP collosol groups were 25.5% and 32.5% respectively, and the gross tumor volumes were obviously less than that of control group. (24.81 ± 5.17 and 22.73 ± 4.23 vs 33.32 ± 5.26, P < 0.05). The tumor control rate of 5-FU group was 43.7% (18.74 ± 4.40 vs 33.32 ± 5.26, P < 0.05), but the general state of the animals after injection aggravated; and the adverse reaction in the drug combination group obviously decreased. Due to the effect of Nano HAP, the positive expression of tumor associated the mutated p53 and c-Myc in tumor tissue was decreased obviously compared with the control group. CONCLUSION: Nano HAP has evident inhibitory action on rabbit implanted hepatic VX_2 tumor in vivo, which may be the result of decreasing the expression of the mutated p53 and c-myc, and drug combination can obviously decrease the adverse reaction of 5-FU.
机译:目的:评价静脉注射羟基磷灰石纳米颗粒(Nano HAP)对家兔肝VX_2移植瘤生长抑制和细胞p53 / c-Myc蛋白表达的抑制作用。方法:将60只肝VX_2荷瘤兔随机分为5组。静脉输注Nano HAP溶胶20 mg / kg,40 mg / kg,5-FU溶液20 mg / mL,5-FU溶液20 mg / mL和Nano HAP溶胶20 mg / kg的混合液,按生理盐水控制。动态检测总体状态,体重,肝功能和总肿瘤体积。用免疫组织化学方法检测肿瘤组织中p53和c-Myc基因蛋白的表达。结果:所有治疗组,注射后3 wk均明显抑制了移植性肝VX_2肿瘤的生长,纳米HAP胶体液组的肿瘤控制率分别为25.5%和32.5%,总肿瘤体积明显小于对照组。对照组。 (24.81±5.17和22.73±4.23与33.32±5.26,P <0.05)。 5-FU组的肿瘤控制率为43.7%(18.74±4.40 vs 33.32±5.26,P <0.05),但注射后动物的总体状态恶化;联合用药组不良反应明显减少。由于纳米HAP的作用,与对照组相比,与p53和c-Myc突变相关的肿瘤的阳性表达明显降低。结论:纳米HAP对兔体内移植的肝VX_2肿瘤具有明显的抑制作用,这可能是由于p53和c-myc基因突变的表达降低,联合用药可明显降低5-FU的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号